Antimicrobial resistance

Collaborating to help curb the spread of resistant infections

Antimicrobials—drugs that kill infectious bacteria, viruses, parasites and fungi—are a mainstay of modern medicine. However, limited development of new medicines and decades of outmoded use have driven increases in the number of microbes resistant to these lifesaving drugs.

Our ongoing efforts align with best practices that control antimicrobial resistance (AMR) and include a broad portfolio of AMR solutions that support the following areas:

  • Infection prevention and control. BD capabilities help reduce the incidence of healthcare-associated infections (HAIs) and the spread of antimicrobial-resistant organisms.
  • Diagnostic testing. BD capabilities enable clinicians to accurately identify infections, appropriately tailor treatment and avoid unnecessary antibiotic use.
  • Surveillance and reporting. BD efforts help identify patients at greatest risk of acquiring resistant infections, monitor population-based trends and provide early warning for outbreaks.

Collectively, these capabilities enhance our customers' ability to contain AMR and achieve effective antimicrobial stewardship. Our recently formed, cross-company AMR team, working with the Office of the UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria, the UK Mission to the United Nations, the Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Unies and the Review on Antimicrobial Resistance, has helped organize forums at events such as the United Nations General Assembly meeting in New York and the World Economic Forum Annual Meeting in Davos, Switzerland. Featured speakers have included Prof. Dame Sally Claire Davies, Chief Medical Officer for England; Lord Jim O'Neill, Chair of the AMR Review and U.K. Commercial Secretary to the Treasury; and Dr. Thomas Frieden, Director of the U.S. Centers for Disease Control and Prevention. At the UN General Assembly meeting, Renuka Gadde from BD Global Health stated that "AMR has no single solution, and the challenges cannot be solved without multiple players working collectively on a common AMR agenda."

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.